Featured by Newsweek & World Class Media Outlets

Interviews

Industry

Jacob Petersen
Jacob Petersen
SVP, Head of Global Nucleic Acid Therapies
Novo Nordisk
2025-04-14

We actively seek partners that complement our expertise, allowing us to accelerate innovation in gene editing and RNAi technologies. The Korro Bio collaboration builds on our RNAi platform but takes a different approach—it focuses on RNA editing rather than silencing genes.

READ MORE
Sean McClain
Sean McClain
Founder & CEO
Absci
2025-04-14

Our strategy is to continue developing these capabilities, and we see the real value not in selling AI as a service, but in using it to create novel biological assets that we can then partner with pharma. That is where differentiation and value lie.

READ MORE
Jerry Murcia
Jerry Murcia
CEO
Montachem International
2025-04-14

Plastic waste is a problem in many parts of the world, especially in poorer regions where families prioritize immediate needs over environmental concerns. While we’re working on a paradigm shift, finding alternative materials to replace plastics will take decades. The process is complex, especially in developing countries, where cost is a major factor.

READ MORE
Michael Willome
Michael Willome
CEO
Synthomer
2025-04-14

We aim for a more balanced global presence, with one-third of our business in America, one-third in Europe, and one-third in Asia. We’re investing more in the US and Asia, including China, and despite uncertainties in the US and China, we believe in their potential for long-term growth, provided risks are managed carefully.

READ MORE
Jim Lassiter
Jim Lassiter
Vice-President/GM
ThermoSafe, Sonoco
2025-04-11

Sonoco’s decision to sell ThermoSafe aligns with its strategy to simplify operations and focus on fewer, larger businesses. Feedback from the investment community has emphasized the complexity of managing a diverse portfolio. By divesting smaller businesses like ThermoSafe, Sonoco can streamline its operations and concentrate on its core franchise platforms, ensuring better alignment with investor expectations.

READ MORE
Dr. Stephen Dilly
Dr. Stephen Dilly
CEO
Codexis
2025-04-11

Codexis is an US enzyme engineering company that develops high-performance enzymes and proteins for applications in pharmaceuticals, biotherapeutics, and molecular diagnostics.

READ MORE
Ivan Tornos
Ivan Tornos
President & CEO
Zimmer Biomet
2025-04-11

Zimmer Biomet is a global medical technology company specializing in orthopaedic implants, surgical robotics, and digital health solutions.

READ MORE
Hans Brok
Hans Brok
President
PHC Corporation of North America
2025-04-11

The Biomedical Division of PHC Corporation, a subsidiary of PHC Group, is a leader in advanced research laboratory equipment and solutions, specializing in technologies for cell and gene therapy development, life sciences research, and scientific instrumentation under the PHCbi brand.

READ MORE
Brent Ragans
Brent Ragans
President
Ferring Pharmaceuticals U.S.
2025-04-11

Ferring Pharmaceuticals is a global biopharmaceutical company focused on scientific innovation in reproductive health, maternal health, gene therapy, and the microbiome.

READ MORE
Alexandria Forbes
Alexandria Forbes
President & CEO
MeiraGTx
2025-04-11

MeiraGTx is a clinical-stage genetic medicine company committed to harnessing the full potential of genetic therapies for both rare and prevalent diseases.

READ MORE